Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

649 ARTÍCULOS , VIENDO DEL 376 AL 390

Familial Adult Myoclonic Epilepsy: Clinical and Genetic Approach to an Under-recognized Disease

Uzun GA, Baykan B.

Noro Psikiyatr Ars. 2023 May 22;60(2):174-177. doi: 10.29399/npa.28252. eCollection 2023.

Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review

Wissel J, Ri S, Kivi A.

Toxicon. 2023 Jun 15;229:107150. doi: 10.1016/j.toxicon.2023.107150. Epub 2023 May 3.

Intracerebroventricular baclofen therapy improves function and quality of life in a child with severe cerebral palsy

Assumpcao de Monaco B, Fruett da Costa PR, Franceschini PR.

Childs Nerv Syst. 2023 Dec;39(12):3639-3642. doi: 10.1007/s00381-023-06084-y. Epub 2023 Jul 29.

TMEM151A as an alternative to PRRT2 in paroxysmal kinesigenic dyskinesia: About three new cases

Mounir Alaoui O, Charbonneau PF, Prin P, Mongin M, Choquer M, Damier P, Riant F, Degos B.

Parkinsonism Relat Disord. 2023 Mar;108:105295. doi: 10.1016/j.parkreldis.2023.105295. Epub 2023 Jan 27.

Improvement in "Jumping Stump" Syndrome Following Diagnostic Sciatic Nerve Block and Home Exercise Program in a Transtibial Amputee

Weinberg D, Tucker B.

Cureus. 2023 Jul 21;15(7):e42278. doi: 10.7759/cureus.42278. eCollection 2023 Jul.

Improvement in Myoclonus-Dystonia Syndrome during Treatment with Gonadotropin-Releasing Hormone Agonist

Moura J, Magalhães M.

Mov Disord Clin Pract. 2023 Sep 25;10(12):1812-1814. doi: 10.1002/mdc3.13883. eCollection 2023 Dec.

Intermittent Ultralow-Frequency Low-Amplitude Deep Cerebellar Stimulation for Movement Disorders

Horisawa S, Qian B, Nonaka T, Kim K, Kawamata T, Taira T.

Mov Disord Clin Pract. 2023 Sep 14;10(11):1683-1686. doi: 10.1002/mdc3.13872. eCollection 2023 Nov.

Adar-associated Aicardi Goutières syndrome in a child with bilateral striatal necrosis and recurrent episodes of transaminitis

van Toorn R, van Niekerk M, Moosa S, Goussard P, Solomons R.

BMJ Case Rep. 2023 Mar 13;16(3):e252436. doi: 10.1136/bcr-2022-252436.

Pearls & Oy-sters: Paroxysmal Exercise-Induced Dyskinesias Due to Pyruvate Dehydrogenase Deficiency

de Gusmao CM, Peixoto de Barcelos I, Pinto ALR, Silveira-Moriyama L.

Neurology. 2023 Jul 4;101(1):46-49. doi: 10.1212/WNL.0000000000207142. Epub 2023 Feb 20.

ATP1A3 related disease manifesting as rapid onset dystonia-parkinsonism with prominent myoclonus and exaggerated startle

Williams L, Waller SE, Bradley M, Lockhart A, Narayanan RK, Kumar KR, Morales Briceno H, Tchan M, Healy DG, Fung VSC.

Parkinsonism Relat Disord. 2023 Dec;117:105864. doi: 10.1016/j.parkreldis.2023.105864. Epub 2023 Oct 5.

De novo retinoic acid receptor beta (RARB) variant associated with microphthalmia and dystonia

Trieschmann G, Wilhelm C, Berweck S, Zech M.

Eur J Med Genet. 2023 Aug;66(8):104802. doi: 10.1016/j.ejmg.2023.104802. Epub 2023 Jun 13.

TorsinA is essential for the timing and localization of neuronal nuclear pore complex biogenesis

Kim S, Phan S, Shaw TR, Ellisman MH, Veatch SL, Barmada SJ, Pappas SS, Dauer WT.

bioRxiv [Preprint]. 2023 Apr 27:2023.04.26.538491. doi: 10.1101/2023.04.26.538491.

Multiple system atrophy associated with Meige syndrome: A rare case report

Liang J, He X, Lu J.

Radiol Case Rep. 2023 Jun 29;18(9):3192-3195. doi: 10.1016/j.radcr.2023.04.055. eCollection 2023 Sep.

Disrupted sleep in dystonia depends on cerebellar function but not motor symptoms in mice

Leon LES, Sillitoe RV.

bioRxiv [Preprint]. 2023 Feb 10:2023.02.09.527916. doi: 10.1101/2023.02.09.527916.

Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report

Hameed M, Siddiqui F, Khan MK, Tadisetty S, Gangishetti PK.

Brain Neurorehabil. 2023 Sep 25;16(3):e25. doi: 10.12786/bn.2023.16.e25. eCollection 2023 Nov.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias